iShares Biotechnology ETF
369 hedge funds and large institutions have $5.23B invested in iShares Biotechnology ETF in 2014 Q4 according to their latest regulatory filings, with 83 funds opening new positions, 107 increasing their positions, 114 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
6% less repeat investments, than reductions
Existing positions increased: 107 | Existing positions reduced: 114
45% less call options, than puts
Call options by funds: $448M | Put options by funds: $821M
Holders
369
Holding in Top 10
25
Calls
$448M
Puts
$821M
Top Buyers
| 1 | +$389M | |
| 2 | +$66.8M | |
| 3 | +$55.5M | |
| 4 |
AssetMark Inc
Concord,
California
|
+$40.3M |
| 5 |
Jane Street
New York
|
+$37M |
Top Sellers
| 1 | -$530M | |
| 2 | -$315M | |
| 3 | -$170M | |
| 4 |
Barclays
London,
United Kingdom
|
-$149M |
| 5 |
JPMorgan Chase & Co
New York
|
-$90.6M |